SANOFINSESanofi India Limited· PharmaceuticalsMinimalNeutral
Announced Wed, 2 Apr · 14:53 IST

Sanofi India Limited has informed the Exchange about Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sanofi India Limited has submitted a disclosure to the stock exchange under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. Regulation 30 requires listed companies to disclose material events or information that could affect share price or investor decisions. The specific nature, subject matter, and details of this disclosure are not available in the filing summary provided, so the underlying event is not identifiable from the available text.

Likely market impact

Without the actual content of the disclosure, it is not possible to assess the impact on shareholders or the stock. Investors should check the full filing on the NSE/BSE website to understand what material information was shared.